Why an ALS Drug Was Pulled From the Market

(MedPage Today) -- DENVER--Topline data presented here showed why Amylyx Pharmaceuticals decided to remove its amyotrophic lateral sclerosis (ALS) drug sodium phenylbutyrate and taurursodiol (Relyvrio), also known as AMX0035, from the market...